Navigation Links
Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks
Date:5/16/2013

Toronto, Canada (PRWEB) May 16, 2013

On average, developing a new drug takes over 10 years and costs over one billion dollars. Despite this investment, less than 10% of drugs make it to market. With stakes this high, is your clinical trial design optimally structured to balance time, cost and risk and deliver the best outcomes?

Dr. Frederic Sax, Global Head of the Center for Drug Development at Quintiles, will discuss the use of data, information and technology in upfront clinical trial planning and design to improve success rates and deliver more cost-effective and timely clinical trials. Topics will include a structured systematic approach to design and its benefits; the need for multiple scenarios to enable more transparent and objective decision making; and the best approach to improving clinical trial execution outcomes.

Webinar attendees will walk away with knowledge in key areas, including:

  •     Best practices for objectively designing your clinical trial
  •     An understanding of how Information can empower expert decisions
  •     Methods for evolving your current culture, methods and approaches to design

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit: http://xtalks.com/xto582quintiles.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year, thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Country and Site Selection: Optimizing Protocol Planning Decisions by Leveraging Data Through Custom Algorithms, New Webinar Hosted by Xtalks
2. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
3. Positive Clinical Study Results for BSPs HyperQ Technology
4. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
5. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
6. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
7. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
8. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
9. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
10. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
11. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... , June 29, 2015 BioNano Genomics, ... of top research institutes, announced today that a collaboration ... Sinai resulted in the creation of the first comprehensive ... single DNA molecule methods for sequencing and genome mapping. ... provided the comprehensive analysis of the contiguous diploid human ...
(Date:6/29/2015)... , June 29, 2015  Neuralstem, Inc. (NYSE ... technology to develop small molecule and cell therapy treatments ... has been approved for listing on the NASDAQ Capital ... will continue to trade on the NYSE MKT until ... the NASDAQ Capital Market is expected to commence on ...
(Date:6/29/2015)... Calif. , June 29, 2015   Veracyte, ... company pioneering the field of molecular cytology, today announced ... News Group,s prestigious Top Workplaces list for the second ... Workplace winners based solely on an annual survey of ... and honored that the degree to which Veracyte values ...
(Date:6/26/2015)... Mass. , June 26, 2015  SeraCare ... vitro diagnostics manufacturers, today announced that it has ... with the National Cancer Institute (NCI), part of ... materials and positive controls for cancer assays.  The ... mix and accurately quantitate control DNA biosynthetics spiked ...
Breaking Biology Technology:BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 2BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date 3Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3SeraCare Life Sciences Signs CRADA with NCI to Advance Cancer Diagnostics 2SeraCare Life Sciences Signs CRADA with NCI to Advance Cancer Diagnostics 3
... CA -- Science fiction fans still have another two months ... of actual science can feast their eyes now on the ... of a graphene crystal. Given that graphene single-layered sheets ... the key to the future of the electronics industry, the ...
... N.C., March 31 Cornerstone Therapeutics Inc. (Nasdaq: ... acquiring, developing and commercializing significant products primarily for the ... and Chief Executive Officer, will be presenting a corporate ... Biotech Industry Conference at 2:00 PM EDT on Thursday, ...
... Joint Venture to be funded by Cadila Pharmaceuticals ... $11 Million Capital Investment in Novavax , ROCKVILLE, ... NVAX ) announced today it has formed ... India) to develop, manufacture and market vaccines, pharmaceuticals ...
Cached Biology Technology:Spring 'blockbuster' movie now showing 2Spring 'blockbuster' movie now showing 3Spring 'blockbuster' movie now showing 4Spring 'blockbuster' movie now showing 5Cornerstone Therapeutics to Present at BioCentury's 2009 Future Leaders in the Biotech Industry Conference 2Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 2Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 3Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 4Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 5Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India 6
(Date:6/24/2015)... 2015 Research and ... the "Huawei Ascend Mate 7 Fingerprint Sensor ... offering. Huawei,s technological choice for the ... than Apple,s and Samsung,s one. The Ascend Mate ... Fingerprint Cards, a main actor in capacitive sensing ...
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
(Date:6/17/2015)... , June 17, 2015  Synaptics Inc. ... interface solutions, today announced that Xiaomi, one of ... Synaptics ® ClearPad ® family of ... driver integrated circuits (DDICs) for its latest smartphones, ... leveraging ClearPad for full in-cell display solutions and ...
Breaking Biology News(10 mins):Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... St. Michael,s hospital have identified 29 proteins that are ... cancer. The discovery will help physicians recognize which tumours ... patients with more intensive treatment and closer followup., "Metastatic ... malignancies and patients have dismal prognosis," said Dr. George ...
... New research that relied in part on satellite images suggests ... the 1800s, is one cause for the larger, hotter and ... of the American West. The arid region covers about 230,000 ... of Utah, Colorado, Idaho, California and Oregon. Bethany Bradley, ...
... fine arts and the exact sciences may appear an ... both. Prof. Karen Avraham and PhD candidate Shaked Shivatzki ... this truth when creating Hearing and Deafness: Structure and ... of Human Genetics art competition. Their work was awarded ...
Cached Biology News:Tracking invasive cheatgrass role in larger, more frequent Western fires 2Tracking invasive cheatgrass role in larger, more frequent Western fires 3Embracing the art of science 2
EPA II Buffer is a diluent formulated to stabilize the activity of Chemicon horseradish peroxidase (HRP)-antibody conjugates at high conjugate dilution for extended periods....
... service, ExonHit can design custom microarrays to ... gene list. Proprietary algorithms are used ... probes from high quality, spliced cDNAs aligned ... contained in a custom SpliceArray is profiled ...
... Visualizer DX's sensitivity of DNA detection has been ... in an agarose gel can be detected > ... can be purified by organic solvent extraction or ... kits worked well.) DNA excised from agarose ...
... SPE Workstation is a modular, highly scalable, ... Utilizing 1ml or 3ml industry standard SPE ... 100 samples in less than two hours ... 10 cartridges, and up to 10 modules ...
Biology Products: